| Literature DB >> 35754552 |
Mayada R Farag1, Mahmoud Alagawany2, Samah R Khalil1, Eman W El-Hady1, Walaa M Elhady1, Tamer Ahmed Ismail3, Carlotta Marini4, Alessandro Di Cerbo4, Hany M R Abdel-Latif5.
Abstract
This study evaluated the immunotoxic effects of thallium (Tl) in Nile tilapia fingerlings and the recovery role of dietary Astragalus membranaceus polysaccharides (ASs). An 8-week experiment was designed where 180 fishes were randomly and equally assigned in triplicates into the six groups: the control group (CNT) was reared in unpolluted water and fed a commercial diet, two groups were fed a well-balanced commercial diet plus 1.5 and 3.0 g AS/kg diet (AS0.15 and AS0.30), respectively, the fourth group was exposed to a sublethal dose of Tl (41.9 μg l-1) [equal to 1/10 of 96-h lethal concentration 50 (LC50)], and the last two groups were fed 0.15 and 0.3% AS, respectively, and concurrently exposed to Tl (41.9 μg l-1) (AS0.15+Tl and AS0.30+Tl). Fish hematobiochemical parameters, serum immunity [nitric oxide, total immunoglobulin M (IgM) levels, and lysozyme activity], transcription of hepatic interferon-γ (IFN-γ), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α), and resistance to Aeromonas hydrophila (A. hydrophila) were assessed. Hematobiochemical parameters and serum immune indices were significantly decreased in the fish group exposed to sublethal Tl concentration compared to the CNT group. Furthermore, Tl exposure significantly induced overexpression of IL-1β, TNF-α, and IFN-γ genes (4.22-, 5.45-, and 4.57-fold higher, respectively) compared to CNT values. Tl exposure also increased the cumulative mortality (%) in Nile tilapia challenged with A. hydrophila. Remarkably, the groups fed AS0.15+Tl and AS0.30+Tl significantly ameliorated all the aforementioned parameters, but did not reach CNT values. Our findings suggest the possible immunomodulating roles of dietary AS in recovering the immunotoxic effects of Tl in Nile tilapia. We can conclude that dietary AS would be useful for maintaining the immunity of Nile tilapia fingerlings.Entities:
Keywords: attenuation; diseases; hematology; herbal medicines; immunity; toxicity
Year: 2022 PMID: 35754552 PMCID: PMC9218348 DOI: 10.3389/fvets.2022.843031
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Ration constituents (g kg−1 diet) and proximate composition analysis of the control diet (35, 55) used in the experiment.
|
|
|
|---|---|
| Soybean meal (SBM; 48% crude protein) | 200 |
| Yellow corn | 210 |
| Fish meal (FM) | 150 |
| Wheat middlings | 150 |
| Corn gluten (CG; 60% crude protein) | 130 |
| Rice bran | 110 |
| Corn oil | 30 |
| Mineral premixa | 10 |
| Vitamin premixb | 10 |
| Total | 1,000 |
|
| |
| Crude protein (CP; %) | 320.5 |
| Crude lipids (CL; %) | 45.50 |
| Crude fiber (CF; %) | 42.45 |
| Ash (%) | 73.01 |
| Nitrogen free extract (NFE)c | 518.54 |
a Mineral premix (Kg.
b Vitamin premix (Kg.
.
Primers sequences used for real-time quantitative PCR (qPCR) analysis.
|
|
| |
|---|---|---|
| IL-1β | F: CAAGGATGACGACAAGCCAACC | XM_003460625.2 |
| IFN-γ | F: AGCACAACGTAGCTTTCCCT | XM_003460533.2 |
| TNF-α | F: CAGGATCTGGCGCTACTCAG | AY428948.1 |
| β-actin | F: CAGGATGCAGAAGGAGATCACA | KJ126772.1 |
IL-1β, Interleukin 1beta; IFN-γ, Interferon gamma; TNF-α, Tumor necrosis factor alpha; β-actin, Beta actin.
Effect of dietary supplementation with Astragalus membranaceus polysaccharides (AS) levels (0.15 and 0.30%) and/or exposure to sublethal thallium (Tl) toxicity [1/10th lethal concentration 50 (LC50); 41.9 μg/l] for 8 weeks on the hematological variables and blood protein profile of Nile tilapia.
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
| Hb (g/dl) | 7.30, 0.34a | 7.70, 0.35a | 7.72, 0.86a | 3.06, 0.38b | 5.35, 0.08c | 5.55, 0.19c |
| RBCs (106/μL) | 2.68, 0.72 | 2.53, 1.04 | 2.80, 0.86 | 2.00, 0.36 | 1.73, 0.36 | 1.80, 0.38 |
| PCV (%) | 25.07, 5.00 | 25.16, 5.07 | 25.35, 5.25 | 20.42, 0.10 | 22.24, 0.46 | 22.50, 0.37 |
| MCV (fl) | 116.38, 1.96c | 111.54, 0.89d | 110.24, 0.58d | 148.05, 1.67a | 131.15, 0.52b | 130.81, 0.23b |
| WBCs (103/ mm3) | 4.99, 0.06b | 5.04, 0.15b | 5.29, 0.06b | 3.68, 0.34a | 4.69, 0.11b | 4.81, 0.13b |
|
| ||||||
| Total protein (g/dL) | 4.24, 0.05a | 4.36, 0.23a | 4.46, 0.44a | 2.65, 0.21b | 2.33, 0.20b | 4.16, 0.13a |
| Albumin (g/dL) | 1.54, 0.12a | 1.58, 0.12a | 1.96, 0.09a | 0.95, 0.04b | 0.93, 0.03b | 1.48, 0.24a |
| Globulin (g/dL) | 2.70, 0.11a | 2.78, 0.35a | 2.50, 0.39a | 1.70, 0.17ab | 1.40, 0.18b | 2.69, 0.17a |
Values are mean ± SEM, values are not sharing a common superscript letter (a, b, c, & d) differ significantly at P <0.05.
Figure 1Serum lysozyme activity (A), immunoglobulin M (IgM) levels (B), myeloperoxidase activity (C), and nitric oxide levels (D) in Nile tilapia fed diets supplemented with Astragalus membranaceus polysaccharides (AS) levels (0.15 and 0.30%) and/or exposed to sublethal thallium (Tl) toxicity [1/10th lethal concentration 50 (LC50); 41.9 μg/l] for 8 weeks. Values are mean ± SE and bars not sharing a common superscript letter (a, b, c, and d) differ significantly at P < 0.05.
Figure 2Messenger RNA (mRNA) expression pattern of interferon-γ (INF-γ) (A), tumor necrosis factor-α (TNF-α) (B), and interleukin-1β (IL-1β) (C) in liver of Nile tilapia fed diets supplemented with Astragalus membranaceus polysaccharides (AS) levels (0.15 and 0.30%) and/or exposed to sub-lethal thallium (Tl) toxicity (1/10th LC50; 41.9 μg/l) for 8 weeks. Values are mean ± SE and bars not sharing a common superscript letter (a, b, c, and d) differ significantly at P < 0.05.
Effect of dietary supplementation with Astragalus membranaceus polysaccharides (AS) levels (0.15 and 0.30%) and/or exposure to thallium (Tl) toxicity (1/10th LC50; 41.9 μg/l) for 8 weeks on the disease resistance of Nile tilapia challenged with Aeromonas hydrophila.
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Total No. of challenged fish | 30 | 30 | 30 | 30 | 30 | 30 |
| Number of dead fish | 2 | 0 | 0 | 7 | 4 | 3 |
| Relative percent survival (RPS) (%) | 93.33 | 100 | 100 | 76.66 | 86.66 | 90 |
| Cumulative mortality rate (CMR) (%) | 6.66 | 0 | 0 | 32.33 | 13.33 | 10.0 |